Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.
Regentis Biomaterials (NYSE American: RGNT) has obtained a Japanese patent allowance that strengthens its intellectual property protection for the organic solvent-free manufacturing process and ready-to-use liquid formulation behind GelrinC, its cell-free hydrogel for knee cartilage repair. This milestone follows a re…
Boostimmune has been granted a Japanese patent covering antibodies that inhibit translationally controlled tumor protein (TCTP) released from dead tumor cells, suppressing myeloid-derived suppressor cell (MDSC) accumulation in the tumor microenvironment. The patent claims are defined by function and therapeutic applic…
Nintendo and The Pokémon Company’s patent lawsuit against Pocketpair, developer of Palworld, centers on game mechanics resembling Pokémon’s catch system. Despite initial claims for injunction and damages, recent legal developments suggest Nintendo’s potential recovery is capped at approximately $30,000, with no impact…
Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.